Discovery of Triterpenoids as Reversible Inhibitors of α/β-hydrolase Domain Containing 12 (ABHD12)

• Teija Parkkari,

  Affiliations School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland

  ⨯
• Raisa Haavikko,

  Affiliation Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  ⨯
• Tuomo Laitinen,

  Affiliation School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland

  ⨯
• Dina Navia-Paldanius,

  Affiliation School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

  ⨯
• Roosa Rytilahti,

  Affiliation School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

  ⨯
• Miia Vaara,

  Affiliation School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

  ⨯
• Marko Lehtonen,

  Affiliation School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland

  ⨯
• Sami Alakurtti,

  Affiliations Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland, VTT Technical Research Centre of Finland, Helsinki, Finland

  ⨯
• Jari Yli-Kauhaluoma,

  Affiliation Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  ⨯
• Tapio Nevalainen,

  Affiliation School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland

  ⨯
• Juha R. Savinainen,

  Affiliation School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

  ⨯
• Jarmo T. Laitinen

  * E-mail: jarmo.laitinen@uef.fi

  Affiliation School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

  ⨯